- Company/Commercial (81)
- Litigation / Dispute Resolution (76)
- Employment (74)
- Tax (65)
- Banking / Finance (62)
- Information Technology (61)
- Intellectual Property (46)
- Corporate (40)
- Healthcare (38)
- Regulatory and compliance (38)
- Media/Entertainment/Sport (34)
- Financial services (32)
- Energy (24)
- Pharma/Biotech (18)
- Insurance/reinsurance (16)
- Competition/EU (15)
- Funds (15)
- Real Estate (15)
- Crime (12)
- Environment (12)
- Transport (Including aviation and shipping) (11)
- Business Tax (9)
- Construction (9)
- Telecoms (9)
- Insolvency & restructuring (8)
- Licensing/Gaming/Betting (8)
- Other (7)
- PPP/PFI/Commercial projects (6)
- Private Equity (5)
- Travel and Tourism (5)
- Pensions (4)
- Planning (4)
- Agriculture (3)
- Clinical/Medical Negligence (2)
- Family (2)
- Human Rights (2)
- In-House (2)
- Personal tax / Trusts (2)
- Immigration (1)
- Public Sector/Local Authority (1)
- Sovereign Wealth (1)
- Suppliers (1)
Sort By: Newest first | Oldest first
The Australian Securities and Investments Commission (ASIC) has announced that its new $43.7m next-generation market surveillance system has become operational.
In this briefing, DLA Piper sets out a summary of key items of interest announced by the chancellor in the UK Autumn Statement.
DLA has released its latest health alert, which includes judgments from Australia, New Zealand, the UK, US and Canada, as well as legislation and reports.
The Australian High Court has delivered its first judgment that directly considers the patentability of methods of medical treatment.
This is the fifth quarterly report of the independent athletics integrity monitor on Penn State’s progress in implementing the requirements of the Athletics Integrity Agreement.
Novation is an important feature of engineering and construction projects — particularly in relation to design and build procurement.
China’s eagerly anticipated amendments to its Trademark Law will come into force on 1 May 2014...
Tougher product liability provisions following the release of long-awaited amendments to consumer rights and interests protection law in China
The rise of consumerism in China over the past 10 years has spurred greater regulatory enforcement in the area of product liability.
The European Commission’s new Cinema Communication 2013 broadens the scope of activities in connection with the creation of films and other audio-visual works that may attract state aid in the member states.
DLA Piper has released the latest issue of its Intellectual Property and Technology News, which includes a piece on Delaware and the final instalment of Trade Dress Watch.
While this agreement is undoubtedly an historic diplomatic coup for the western diplomacy, the interim Geneva deal remains limited.
The tax deduction for advertising expenses has clearly become a target for Congressional tax reformers.
This briefing includes a capsule review of the relevant provisions of the Dodd-Frank Act that were crafted to enhance corporate responsibility.
Part II provides an overview of the procurement process and what Japan is likely to expect from tenderers from commercial, compliance and cultural perspectives.
In the mobile environment, data can be collected and shared with ease. Each individual’s privacy must be strictly protected, no matter what platform/technology is used.
DLA Piper has released the 2 December 2013 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
Amendments to the auto-enrolment legislation to take account of practical experience came into force at the beginning of this month.
IVASS has launched a survey on the sale of insurance policies (typically in the form of group policies) in conjunction with non-insurance products or services.
ASIC is proposing to update and broaden its current employee share scheme class-order relief and regulatory guidance in response to developments in market practice and the need for clarity.
A recent decision by the Court of Appeal provides useful guidance on the correct approach to defining the market in relation to pharmaceutical products.